Global Regenerative Medicines Market Overview:
Global regenerative medicines market is projected to reach $ 30,237 million by 2022. Cell therapy segment is expected to dominate the market throughout the forecast period. North America led the global market in 2015, and is expected to remain dominant during the 2015-2022.
Regenerative medicines have the ability to repair, replace, and regenerate tissues and organs affected due to injury, disease, or natural ageing process. These medicines are capable of restoring the functionality of cells & tissues and are applicable in a wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers focus on developing technologies based on biologics, genes, somatic as well as stem cells. Stem cells are capable of proliferation and differentiation owing to which they are of importance in this field. Currently, majority of treatments available for degenerative or life-threatening diseases do not provide a cure or are palliative; however, regenerative medicines have the capability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the utilization of nano-materials in wound care, drug delivery, and immunomodulation creates growth avenues for the regenerative medicines market.
The major factors boosting the market growth include technological advancements in tissue and organ regeneration, increasing prevalence of chronic diseases and trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, increasing incidence of degenerative diseases and shortage of organs for transplantation are expected to boost the growth of the market. The prominent potential of regenerative medicine to replace, repair, and regenerate damaged tissues and organs has boosted the market growth. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened growth avenues for the regenerative medicines market. However, stringent regulatory barriers and high cost of the treatment are likely to hinder the market growth.
Top investment pockets
North America is the most attractive region in the global regenerative medicines market and is expected to be the first preference for new entrants due to the increasing end-use applications in the region. The North American regenerative medicines market is in its growing phase and is expected to exhibit high potential in future, as most of the therapies are in the 3rd phase of clinical trials. This shows the intervention of companies for commercialization of regenerative medicine products. Favorable regulatory and reimbursement policies for tissue engineering shows interest of government authorities fulfilling the growing need of regenerative products. However, stringent regulatory policies pertaining to stem cell technologies have posed major challenges for the adoption of embryonic stem cells, owing to ethical issues and controversies regarding its source; thereby, restricting the market growth. Consumer awareness regarding the benefits of regenerative medicine has increased in the recent years, which has influenced the demand. The North American regenerative market is expected to grow at a CAGR of 32.5% from 2016 to 2022. Europe is the second most attractive market for new entrants in the regenerative medicine market, which is expected to grow at a CAGR of 31.2%. Asia-Pacific region is growing at a CAGR of 39.9%.
The regenerative medicine materials market is segmented into three broad categories, namely, synthetic materials, biologically derived materials, and genetically engineered materials. The demand for synthetic and biological derived materials is high in the market due to the presence of remarkable characteristics such as cellular adoption and higher immune response. Tissue engineering and regenerative medicine are widely used in the biomedical sector for regeneration and repair of diseased tissue or trauma tissues. Tissue regeneration can be conducted both in vitro and in vivo conditions. Tissue engineering requires artificial matrix for regeneration of tissues. This artificial matrix aids in the proliferation and differentiation of cells, leading to regeneration of tissues. The demand for synthetic tissue engineering materials is currently high due to its higher efficiency as compared to other naturally derived materials. The global market for tissue engineering generally prefers biologically derived materials, as they provide better outcome during the procedures.
Top players in the market are investing huge capital in R&D activities to develop enhanced products, in order to cater current demand. Some of the major players in the regenerative medicines market are Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International, Inc., DePuy Synthes, Organogenesis, Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics, Inc. (Astellas Pharma, Inc.), and CryoLife, Inc.
Raw Material Analysis
The demand for biologically derived materials for regenerative medicine is currently high due to its efficiency over other naturally derived materials. During the procedures, synthetic materials are more used compared to others, as they provide better outcome during the procedures. Synthetic polymers play a key role in regenerative medicine products. Currently, novel synthetic biomaterials are developed for the use of three-dimensional extracellular microenvironments. Increase in demand for material reengineering and cell biology would result in the development of synthetic materials, which comprise necessary processes that are used in tissue and organ-specific differentiation and morphogenesis.
GLOBAL SYNTHETIC MATERIAL REVENUE, 2015‐2022 ($ MILLION)
The recent progress in the design of synthetic materials have led to the use of hydrogel in tissue-engineered scaffolds. These synthetic materials comprises interlinked polymers that form a network-like structure through physical and chemical cross-linking. Although the synthetic materials used in tissue engineering hold promising potential in the market in terms of revenue, it may face challenges from the external market forces. Combination materials and time-sensitive use of materials are expected to be crucial factors for choosing synthetic materials in future.
KEY BENEFITS OF REGENERATIVE MEDICINES MARKET
- The report provides an in-depth analysis of the global regenerative medicines market and future estimations, in terms value, from 2016 to 2022, including information about the current market situation, changing market dynamics, expected trends, and market intelligence.
- The factors that drive and impede the growth of the global market are comprehensively analyzed in this study.
- SWOT analysis highlights the internal environment of leading companies for effective strategy formulation.
- The report contains a comprehensive study of the key strategies adopted by companies to gain traction in the market.
- Micro-level analysis is conducted based on technology, material, application, and region.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
REGENERATIVE MEDICINES MARKET SEGMENTS
The regenerative medicines market is segmented on the basis of type, source, application, and geography.
- Cell Therapy
- Gene Therapy
- Tissue Engineering
- Small Molecules & Biologics
- Synthetic Materials
- Biodegradable Synthetic Polymers
- Artificial Vascular Graft Materials
- Hydrogel Material
- Biologically Derived Materials
- Xenogeneic Material
- Genetically Engineered Materials
- Deoxyribonucleic Acid Transfection Vectors
- Genetically Manipulated Cells
- Three-Dimensional Polymer Technology
- Neural Stem Cells
- Gene-Activated Matrices
- Small Molecules
- Wound Healing
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Republic of South Africa
- Rest of LAMEA